Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 03-2012 | 02-2012 | 12-2011 | 11-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -409 | -2,238 | N/A | N/A | -1,821 |
| Depreciation Amortization | 15 | 62 | N/A | 53 | 53 |
| Accounts payable and accrued liabilities | -42 | N/A | 73 | N/A | 47 |
| Other Working Capital | 21 | 686 | N/A | 570 | 570 |
| Other Operating Activity | 270 | 1,038 | -73 | 835 | 787 |
| Operating Cash Flow | $-145 | $-452 | $N/A | $1,458 | $-364 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | N/A | -47 | -47 |
| Other Investing Activity | -198 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-198 | $-4 | $N/A | $-47 | $-47 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 93 | N/A | 50 |
| Common Stock Issued | 344 | N/A | 241 | N/A | 236 |
| Other Financing Activity | -2 | 339 | -334 | 286 | 5 |
| Financing Cash Flow | $342 | $339 | $N/A | $286 | $291 |
| Beginning Cash Position | 12 | 128 | N/A | N/A | 128 |
| End Cash Position | 12 | 12 | N/A | N/A | 9 |
| Net Cash Flow | $0 | $-117 | $N/A | $1,697 | $-120 |
| Free Cash Flow | |||||
| Operating Cash Flow | -145 | -452 | N/A | 1,458 | -364 |
| Capital Expenditure | N/A | N/A | -4 | N/A | -47 |
| Free Cash Flow | -145 | -452 | -4 | 1,458 | -411 |